Interferon—Present and Future Prospects

References

• Adolf G. R., Swetly P. Interferon production in human hematopoietic cell lines: response to chemicals and characterization of interferons. J. Interferon Res. 1982; 2: 261
   PubMedGoogle Scholar
• Anand S. C., Itkin I. H., Kind L. S. Effect of influenza vaccine on methacholine sensitivity in patients with asthma of known and unknown origin. J. Allergy 1968; 42: 187
   Google Scholar
• Atherton K. T., Burke D. C. The effects of some different metabolic inhibitors on interferon superinduction. J. Gen. Virol. 1978; 41: 229
   Google Scholar
• Baglionl C., Minks M. A., Maroney P. A. Interferon action may be mediated by activation of a nuclease by pppA2iˇ p5iˇ, A2iˇ p5iˇ A. Nature (London) 1978; 273: 684
   Google Scholar
• Balkwill F., Taylor-Papadimitriou J. Interferon affects both G1 and S + G2 in cells stimulated from quiescence to growth. Nature (London) 1978; 274: 798
   PubMedGoogle Scholar
• Ball L. A. Induction of 2iˇ5iˇ-oligoadenylate synthetase activity and a new protein by chick interferon. Virology 1979; 94: 282
   PubMedGoogle Scholar
• Ball L. A., White C. N. Nuclease activation by double-stranded RNA and by 2iˇ,5iˇ-oligoadenylate in extracts of interferon-treated chick cells. Virology 1969; 93: 348
   Google Scholar
• Basham T. Y., Bourgeade M. F., Creasey A. A., Merigan T. C. Interferon increases HLA synthesis in melanoma cells: Interferon-resistant and -sensitive cell lines. Proc. Natl. Acad. Sci. 1982; 79: 3265
   PubMed Web of Science ®Google Scholar
• Beck J., Brunner H., Marchuchi F., Cuschner H., Wisenbern J. Induction of IFN by micoplasmas and mouse spleen cell cultures. J. IFN Res. 1982; 2: 1
   Google Scholar
• Berkovich S., Milliam S. J., Snyder R. D. The association of viral and mycoplasma infections with recurrence of wheezing in the asthmatic child. Ann. Allergy 1970; 28: 43
   PubMedGoogle Scholar
• Billiau A., DeSomer P., Edy V. G., DeClercq E., Heremans H. Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans. Antimicrob. Agents Chemother. 1979; 16(1)56
   Google Scholar
• Bino T., Madar Z., Gertler A., Rosenberg H. The kidney is the main site of interferon degradation. J. Interferon Res. 1982; 2(2)301
   Google Scholar
• Blalock J. E., Georgiades J. A., Langford M. P., Johnson H. M. Purified human immune interferon has more potent anti-cellular activity than fibroblast or leukocyte interferon. Cell. Immunol. 1980; 49: 390
   PubMed Web of Science ®Google Scholar
• Blalock J. E., Smith E. M. Human leukocyte interferon (HuIFN-α): potent endorphin-like opioid activity. Biochem. Biophys. Res. Commun. 1981; 101(2)472
   Google Scholar
• Blalock J. E., Stanton J. D. Common pathways of interferon and hormonal action. Nature (London) 1980; 283: 406
   PubMedGoogle Scholar
• Bloom B. R. Interferons and the immune system. Nature (London) 1980; 284: 593
   PubMed Web of Science ®Google Scholar
• Bocci V. Production and role of interferon in physiological conditions. Biol. Rev. 1981; 56: 49
   PubMedGoogle Scholar
• Borden E. C. Perspective. Interferons: rationale for clinical trials in neoplastic disease. Ann. Int. Med. 1979; 91: 472
   PubMed Web of Science ®Google Scholar
• Borden E. C., Hawkins J. J. Interferons for human neoplastic and viral diseases. Comprehensive Ther. 1980; 6: 6
   Google Scholar
• Bordon E. C., Holland J. F., Dao T. L., Gutterman J. U., Wiener L., Chang Y., Patel J. Leukocyte derived IFN (alpha) in human breast carcinoma, human cancer society Phase II trial. Ann. Int. Med. 1982; 97: 1
   Google Scholar
• Borgstrom S., Edler von Eyben F., Flodgren P., Axelsson B., Sjogren H. O. Human leukocyte interferon and cimetidine for metastatic melanoma. N. Engl. J. Med. 1982; 307: 1080
   PubMed Web of Science ®Google Scholar
• Bradley E. C., Ruscetti F. W. Effect of fibroblast, lymphoid and myeloid interferons on human tumor colony formation in vitro. Cancer Res. 1981; 41: 244
   PubMed Web of Science ®Google Scholar
• Breinig M. C., Ho M., White L., Armstrong J. A., Pazin G. J., Haverkos H. W., Cantell K. Effect of prolonged administration of interferon-alpha on pharmacokinetics, fever, lymphocyte proliferation response, and NI cell activity. J. Interferon Res. 1982; 2(2)195
   Google Scholar
• Burke D. C., Graham C. F., Lehman J. M. Appearance of interferon inducibility and sensitivity during differentiation of murine teratocarcinoma cells in vitro. Cell 1978; 13: 243
   PubMed Web of Science ®Google Scholar
• Calvet M. C., Gresser P. Interferon enhances the excitability of cultural neurones. Nature (London) 1979; 278: 5585
   Google Scholar
• Cantell K., Hirvonen S. Large scale production of human leukocyte interferon containing 108 units/mℓ. J. Gen. Virol. 1978; 39: 541
   PubMed Web of Science ®Google Scholar
• Cantell K., Hirvonen S. Preparation of human leukocyte interferon for clinical use. The interferon system: a current review to 1978. Tex. Rep. Biol. Med. 1977; 35: 138
   Google Scholar
• Cantell K., Pyhala L. Pharmacokinetics of human interferons. J. Infect. Dis. 1976, A.: 6
   Google Scholar
• Cantell K., Strander H., Saxen L., Meyer B. Interferon response of human leukocytes during intrauterine and postnatal life. J. Immunol. 1968; 100: 1304
   Google Scholar
• Cerottini J. C., Brunner K. T., Lindahl P., Gresser I. Inhibitory effect of interferon preparations and inducers on the multiplication of transplanted allogenetic spleen cells and syngenic bone marrow cells. Nature New Biol. 1973; 242: 152
   PubMedGoogle Scholar
• Chany C., Duc-Goiran P., Chudzio T., Lebon P., Robert-Galliot B. Presence of interferons in human amniotic fluid (Abstr. 023). J. Cell. Biochem. 1982; 6: 83, (Suppl.)
   Google Scholar
• Chany C., Gregoire A., Vignal M., Lemaitre-Moncutt J., Brown P., Besancon F., Suarez H., Cassingena R. Mechanism of interferon uptake in parental and somatic monkey-mouse hybrid cells. Proc. Natl. Acad. Sci. 1973; 70: 557
   Google Scholar
• Chany C., Rousset S., Bourgeade M. F., Mathieu D., Gregoire A. Role of receptors and the cytoskeleton in reverse transformation and steroidogenesis induced by interferon. Ann. N.Y. Acad Sci. 1980; 350: 254
   PubMedGoogle Scholar
• Cheeseman S. H., Rubin R. H., Stewart J. A., Tolkoff-Rubin N. E., Cosimi A. B., Cantell K., Gilbert J., Winkel S., Herrin J. T., Black P. H., Russell P. S., Hirsch M. S. Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects of cytomegalovirus and herpes simplex virus infections. N. Engl. J. Med. 1979; 300: 1345
   PubMed Web of Science ®Google Scholar
• Chirigos M. A., Schultz R. M., Stylos W. A. Interaction of interferon, macrophage and lymphocyte tumoricidal activity with prostaglandin effect. Ann. N.Y. Acad. Sci. 1980; 350: 91
   Google Scholar
• Chisholm M., Cartwright T. Interferon production in leukemia. Br. J. Hematol. 1978; 40: 43
   Google Scholar
• Cioe L., O'Brien T. G., Diamond L. Inhibition of adipose conversion of BALB/c3T3 cells by interferon and 12–0-tetradecanoyl pharbol-13-acetate. Cell. Biol. Int. Rep. 1980; 4: 255
   Google Scholar
• Clemens M. J., Williams B. R. G. Inhibition of cell-free protein synthesis by ppA2iˇp5iˇA2iˇp5iˇA: A novel oligonucleotide synthesized by interferontreated L-cell extracts. Cell 1978; 13: 565
   PubMed Web of Science ®Google Scholar
• Content J., DeWitt L., Pierard D., Derynck R., DeClercq E., Fiers W. Secretory proteins induced in human fibroblasts under conditions used for the production of interferon B. Proc. Natl. Acad. Sci. 1982; 79: 2768
   PubMed Web of Science ®Google Scholar
• Creasey C. A., Bartholomew J. C., Merigan T. C. Role of G0-G1 arrest in the inhibition of tumor cell growth by interferon. Proc. Natl. Acad. Sci. U.S.A. 1980; 77: 1471
   PubMed Web of Science ®Google Scholar
• Cuatrecasas P. Interaction of insulin with the cell membrane: the primary action of insulin. Proc. Natl. Acad. Sci. U.S.A. 1969; 63: 450
   PubMed Web of Science ®Google Scholar
• Czarniecki C. W., Streevalsan T., Friedman R. M., Panet A. Dissociation of interferon effects on murine leukemia virus and encephalomyocarditis virus replication in mouse cells. J. Virol. 1981; 37: 827
   PubMedGoogle Scholar
• Dawson A. A., Forman D. M., Entrican J. H. Appendectomy and tonsillectomy in patients with lymphomas. Clin. Oncol. 1979; 5: 221
   Google Scholar
• DeHaro C., Ochoa S. Mode of action of the hemin-controlled inhibitor of protein synthesis: studies with factors from rabbit reticulocyte lysates. Proc. Natl. Acad. Sci. 1978; 75: 2713
   Google Scholar
• DeKoning E. W. J., Van Bijsterveld O. P., Cantell K. Combination therapy for dendritic keratitis with human leucocyte interferon and trifluorothymidine. Br. J. Ophthalmol. 1982; 66: 509
   Google Scholar
• Dianzani F., Baron S. Unexpectedly rapid action of human interferon in physiological conditions. Nature (London) 1975; 257: 682
   Google Scholar
• Dianzani F., Levy H. B., Berg S., Baron S. Kinetics of the rapid action of interferon (39447). Proc. Soc. Exp. Biol. Med. 1976; 152: 593
   Google Scholar
• Dianzani F., Monahan T. M., Santiamo M. Membrane alteration responsible for the induction of gamma interferon. Infect. Immunity 1982; 36(3)915
   Google Scholar
• Dianzani F., Monahan T. M., Scupham A., Zucca M. Enzymatic induction of interferon production by galactose oxidase treatment of human lymphoid cells. Infect. Immunity 1979; 26: 879
   Google Scholar
• Distafano, et al. Lupus-like IFN and immuno-deficiency syndrome. J. Infect. Dis. 1982; 146: 451
   Google Scholar
• Donahoe R. M., Huang K. Y. Interferon preparations enhance phagocytosis in vivo. Infect. Immunol. 1976; 13: 1250
   PubMedGoogle Scholar
• Dunnick J. K., Glasso G. J. Clinical trials of exogenous interferon: summary of a meeting. J. Infect. Dis. 1979; 139: 109
   Google Scholar
• Einhorn S., Ahre A., Blomgren H., Johansson B., Mellstedt H., Strander H. Interferon and natural killer activity in multiple myeloma. Lack of correlation between interferon-induced enhancement of natural killer activity and clinical response to human interferon-α. Int. J. Cancer 1982; 30: 167
   PubMedGoogle Scholar
• Eisen A. H. The role of infection in allergic disease. Pediatr. Clin. N. Am. 1969; 16: 67
   Google Scholar
• Emodi G., Just M. Impaired interferon response of children with congenital cytomegalic virus disease. Acta Paediat. Scand. 1974; 63: 183
   PubMed Web of Science ®Google Scholar
• Empey D. W., Laitinen L. A., Jacobs L., Gold W. M., Nadel J. A. Mechanism of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am. Rev. Respir. Dis. 1976; 113: 131
   PubMed Web of Science ®Google Scholar
• Eppstein D. A., Peterson T. C., Samuel C. E. Mechanism of interferon action: Synthesis and activity of the interferon-mediated low-molecular-weight oligonucleotide from murine and human cells. Virology 1979; 98: 9
   Google Scholar
• Epstein L. B., Cline M. J. Chronic lymphocytic leukemia: studies on mitogen stimulated lymphocyte interferon as a new technique for assessing T lymphocyte effector function. Clin. Exp. Immunol. 1974; 16: 553
   Google Scholar
• Epstein L. B. Interferon-gamma: success, structure and speculation. Nature (London) 1982; 295: 453
   PubMedGoogle Scholar
• Epstein L. B., Lee S. H. S., Epstein C. J. Enhanced sensitivity of trisomy 21 monocytes to the maturation-inhibiting effect of interferon. Cell. Immunol. 1980; 50: 191
   Google Scholar
• Epstein L. B., Rose M. E., McManus N. H., Li C. H. Absence of functional and structural hemology of natural and recombinate human leukocyte interferon (IFN-alpha) with human alpha-ACTH and beta-endorphin. Biochem. Biophys. Res. Commun. 1982; 104: 341
   Google Scholar
• Epstein L. B., Shen J. T., Abele J. S., Reese C. C. Sensitivity of human ovarian carcinoma cells to interferon and other antitumor agents as assessed by an in vitro semi-solid agar technique. Ann. N.Y. Acad. Sci. 1980; 350: 228
   Google Scholar
• Ernestoff M. S., Davis C. A., Ferraresi R. W., Rudnick S., Kirkwood J. M. Toxicity and antitumor effects of daily recombinant human IFN-α. 1982, Abstract Eastern Section AFCR
   Google Scholar
• Evinger M., Rubinstein M., Peska S. Growth-inhibitory and anti-viral activity of purified leukocyte interferon. Ann. N.Y. Acad. Sci. 1980; 350: 399
   Google Scholar
• Falcoff E., Falcoff R., Lebleu B., Revel M. Correlation between the antiviral effect of interferon treatment and the inhibition of in vitro mRNA translation in noninfected L cells. J. Virol. 1973; 12: 421
   Google Scholar
• Falcoff R., Sanceau J. Mengovirus-induced inhibition of cell protein synthesis and subsequent recovery of cellular activity in interferon pretreated cells. Virology 1979; 98: 433
   Google Scholar
• Fauconnier B. Large scale production of human interferon from human spleens. J. Interferon Res. 1980; 1: 1517
   Google Scholar
• Field A., Tytell A., Lampson G., Hilleman M. Inducers of interferon in host resistance. II. Multistranded synthetic polynucleotide complexes. Proc. Natl. Acad. Sci. 1967; 58: 1004
   PubMed Web of Science ®Google Scholar
• Floyd-Smith G., Slattery E., Lengyel P. Interferon action: RNA cleavage pattern of a (2iˇ-5iˇ) oligoadenylate-dependent endonuclease. Science 1981; 212: 1030
   PubMed Web of Science ®Google Scholar
• Friedman R. M. Antiviral activity of interferon. Bacterial Rev. 1977; 41: 543
   PubMedGoogle Scholar
• Friedman R. M. Cell surface alterations induced by interferon methods. Enzymology 1981; 79: 458
   Google Scholar
• Friedman R. M. Interferon binding: the first step in establishment of antiviral activity. Science 1967; 156: 1760
   PubMed Web of Science ®Google Scholar
• Friedman R. M., Chang E. H. Interferon Action: Possible Mechanisms of Antiviral Activity, W. E. Stewart, II. CRC Press, Boca Raton, Fla 1977; 145
   Google Scholar
• Friedman R. M. Inhibition of arborvirus protein synthesis by interferon. J. Virol. 1968; 2: 1081
   Google Scholar
• Friedman R. M., Metz D. H., Esteban R. M., Tovell D. R., Ball L. A., Kerr I. M. Mechanism of interferon action inhibition of viral messenger ribonucleic acid translation in L-cell extracts. J. Virol. 1972; 10: 1184
   Google Scholar
• Friedman R. M., Pastan I. Interferon and cyclic-3iˇ-5iˇ-adenosine monophosphate: potentiation of antiviral activity. Biochem. Biophys. Res. Commun. 1969; 36: 735
   PubMed Web of Science ®Google Scholar
• Friedman R. M., Sonnabend J. A. Inhibition of interferon action by puromycin. J. Immunol. 1965; 95(4)696
   Google Scholar
• Gadzik J. P., Alinaji, Barker C. F., Blank K. J. Inhibition of virus-induced murine diabetes by an interferon inducer. J. Interferon Res. 1982; 2: 59
   Google Scholar
• Gewert D. R., Clemens M. J. Inhibition of interferon of thymidine uptake and deoxyribonucleic acid synthesis in human lymphoblastoid cells. Biochem. Soc. Trans. 1980; 8: 353
   Google Scholar
• Gewert D. R., Shah S., Clemens M. J. Inhibition of cell division by interferons: changes in the transport and intracellular metabolism of thymidine in human lymphoblastoid (Daudi) cells. Eur. J. Biochem. 1981; 116: 487
   PubMedGoogle Scholar
• Gifford G. E., Koch A. L. The interferon dose response curve and its possible significance. J. Theor. Biol. 1969; 22: 271
   Google Scholar
• Gobel U., Arnold W., Wahn V., Treuner J., Jurgens H., Cantell K. Comparison of human fibroblast and leukocyte interferon in the treatment of severe laryngeal papillomatosis in children. Eur. J. Pediatr. 1981; 137: 175
   Google Scholar
• Gober L. L., Friedman-Kien A. E., Havell E. A., Vilcek J. Suppression of the intracellular growth of Shigella flexneri in cell cultures by interferon preparations and polyinosinic-polycytidylic acid. Infect. Immunol. 1972; 5: 370
   PubMedGoogle Scholar
• Goepfert H., Gutterman J. U., Dichtel W. J., Sessions R. B., Cangir A., Sulek M. Leukocyte interferon in patients with juvenile laryngeal papillomatosis. Ann. Otol. Rhinol. Laryngol. 1982; 91: 431
   PubMed Web of Science ®Google Scholar
• Goodwin J. S., Webb D. R. Review: Regulation of the immune response by prostaglandins. Clin. Immunol. Immunopathol. 1980; 15: 106
   PubMedGoogle Scholar
• Gordon J., Minks M. A. The interferon renaissance: molecular aspects of induction and action. Microbiol. Rev. 1981; 45(2)244
   Google Scholar
• Gray P. W., Goeddel D. V. Structure of the human immune interferon gene. Nature (London) 1982; 298: 859
   PubMed Web of Science ®Google Scholar
• Green J. A. Inhibition of Shigella flexneri by lysates of cells treated with interferon-containing preparations. Infect. Immunol. 1973; 7(6)1006
   Google Scholar
• Greenberg H. B., Pollard R. B., Lutwich L. I., Gregorn P. O., Robinson W. S., Merrigan T. C. Effect of human leukocyte interferon on hepatis B virus infection in patients with chronic active hepatitis. N. Engl. J. Med. 1976; 295: 517
   PubMed Web of Science ®Google Scholar
• Greeser I., Bandu M., Brouty-Boye D., Tovey M. Pronounced antiviral activity of human interferon on bovine and porcine cells. Nature (London) 1974; 251: 543
   Google Scholar
• Greeser I., Morel-Morager L., Riviere Y., Guillon J., Tovey M., Woodrow D., Sloper J., Moss J. Interferon induced disease in mice and rats. Ann. N.Y. Acad. Sci. 1980; 350: 12
   Google Scholar
• Gresser I., Tovey M. G., Maury C., Couroulinkoy I. Lethality of interferon preparations for newborn mice. Nature (London) 1975; 285: 76
   Google Scholar
• Gresser I., Morel-Maroger L., Chatelet F., Maury C., Tovey M., Bandu M.-T., Buywid J., Delauche M. Delays in growth and the development of nephritis in rats treated with interferon preparations in the neonatal period. Am. J. Pathol. 1979; 95: 329
   PubMed Web of Science ®Google Scholar
• Grossbery S. E. The interferons and their inducers: molecular and therapeutic considerations. N. Engl. J. Med. 1972; 287: 13, 287, 79, 1972; 287, 122, 1972.
   Google Scholar
• Grossberg S. E., Morahan P. S. Repression on interferon action: induced differentiation of embryonic cells. Science 1971; 171: 77
   Google Scholar
• Gupta S. L., Sopori M. L., Lengyel P. Inhibition of protein synthesis directed by added viral and cellular messenger RNAs in extracts of interferon-treated Ehrlich ascites tumor cells. Location and dominance of the inhibitor(s). Biochem. Biophys. Res. Commun. 1973; 54: 777
   Google Scholar
• Gutterman J. U., Fine S., Quesada J., Horning S. J., Levine J. F., Alexanian R., Colburn W., Trown P., Merigan T., Dziewanowski Z. Recombinant leukocyte A interferon: Parmacokinetics, single-dose tolerance, and biological effects in cancer patients. Ann. Int. Med. 1982; 96: 549
   PubMed Web of Science ®Google Scholar
• Gutterman J. U., Blumenschien G. R., Alexanian R., Yap H., Buzdar A. U., Cabanillas F., Hortobagyi G. N., Hersh E. M., Rasmussen S. L., Harmon M., Kramer M., Pestka S. Leukocyte interferon-induced tumor regression in hyman metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann. Int. Med. 1980; 93: 399
   PubMed Web of Science ®Google Scholar
• Haglund S., Lundquist Perk, Cantell K., Strander H. Interferon therapy in juvenile laryngeal papillomatosis. Arch. Otolaryngol. 1981; 107: 327
   PubMed Web of Science ®Google Scholar
• Hahn T., Levine S., Handzel Z. T. Production of immune and viral interferon by lymphocytes of newborn infants. Isr. J. Med. Sci. 1980; 16: 33
   Google Scholar
• Hahn T., Levine S. The interferon system in patients with malignant disease. J. INF Res. 1982; 2: 97
   Google Scholar
• Handa K., Suzuki R., Matsui H., Shimizu Y., Kumagai K. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). J. Immunol. 1983; 130: 988
   PubMed Web of Science ®Google Scholar
• Harfast B., Huddlestone J. R., Casali P., Merigan T. C., Oldstone M. B. A. Interferon acts directly on human B lymphocytes to modulate immunoglobulin synthesis. J. Immunol. 1981; 127(5)2146
   Google Scholar
• Harmon M. W., Greenberg S. B., Couch R. B. Effect of human nasal secretions on the antiviral activity of human fibroblast and leukocyte interferon (39448). Proc. Soc. Exp. Biol. Med. 1976; 152: 598
   Google Scholar
• Harned C. L., Nerland D. E., Sonnenfeld G. Effects of passive transfer induction of gamma (Type II immune) interferon preparations on the metabolism of diphenylhydantoin by murine cytochrome P-450. J. Interferon Res. 1982; 2: 5
   PubMedGoogle Scholar
• Havell E. A., Vilcek J. Production of high-titered interferon in cultures of human diploid cells. Antimicrob. Agents Chemother. 1972; 2: 476
   PubMedGoogle Scholar
• Heine J. W., Adler W. H. The quantitative production of interferon by mitogen-stimulated mouse lymphocytes as a function of age and its effect on the lymphocytes proliferative response. J. Immunol. 1977; 118: 1366
   Google Scholar
• Herberman R. B., Ortaldo J. R., Djeu J. Y., Holden T., Jett J., Lang N. O., Rubinstein M., Pestka S. Role of interferon in regulation of cytotoxicity by natural killer cells and macrophages. Ann. N.Y. Acad. Sci. 1980; 350: 63
   Google Scholar
• Herberman R. B., Ortaldo J. R. Natural killer cells: their role in defenses against disease. Science 1981; 214: 24
   PubMed Web of Science ®Google Scholar
• Hilfenhaus J., Mauler R. Human fibroblast and human leukocyte interferon: their differences in cell growth and inhibition activities on lymphoblastoid cells. Ann. N.Y. Acad. Sci. 1980; 350: 626
   Google Scholar
• Hill N. O., Pardue A., Khan A., Hill R. W., Aleman C., Hilario, Hill J. M., Osther K. Interferon and cimetidine for malignant melanoma. N. Engl. J. Med. 1983; 308: 286
   PubMed Web of Science ®Google Scholar
• Ho M. Interferon-light viral inhibitor in rabbits after intravenous administration of enterotoxin. Science 1964; 146: 14
   Google Scholar
• Ho M. Patterns of interferon appearances in mice injected with bacteria or bacterial endotoxin. Nature (London) 1964; 204: 1712
   Google Scholar
• Ho M., Armstrong J. A. Interferon. Ann. Rev. Microbiol. 1975; 29: 131
   PubMed Web of Science ®Google Scholar
• Honigsberger L., Fielding J. W., Prestman T. J. Neurological effects of recombinant human interferon. Br. Ned. J. 1983; 286: 719
   Google Scholar
• Hooks J. J., Moutsopoulos H. M., Notkins A. L. The role of interferon in immediate hypersensitivity and autoimmune diseases. Ann. N.Y. Acad. Sci. 1980; 350: 21
   Google Scholar
• Hooks J. J., Moutsopoulus H. N., Geis S. A., Stahl N. I. L., Notkins A. L. Immune interferon in the circulation of patients with autoimmune disease. N. Engl. J. Med. 1979; 301: 5
   PubMed Web of Science ®Google Scholar
• Hovanessian A. G., Brown R. E., Kerr I. M. Synthesis of low modular weight inhibitor of protein synthesis with enzyme from interferon treated cells. Nature (London) 1979; 268: 537
   Google Scholar
• Huang K. Y., Donahoe R. M., Gordon F. B., Dressier H. R. Enhancement of phagocytosis by interferon-containing preparations. Infect. Immunol. 1976; 4: 581
   Google Scholar
• Huhti E. T., Mokka T., Nikoskelainen J., Halonen P. Association of viral and mycoplasma infections with exacerbations of asthma. Ann. Allergy 1974; 33: 145
   Google Scholar
• Ida S., Hooks J. J., Siraganian R. P., Notkins A. L. Enhancement of IgE-mediated histamine release from human basophils by viruses: role of interferon. J. Exp. Med. 1977; 145: 892
   PubMed Web of Science ®Google Scholar
• Imanishi J., Karaki T., Sasaki O., Matsuo A., Oishi K., Pak C., Kishida T., Toda S., Nagata H. The preventive effect of human interferon-alpha preparation on upper respiratory disease. J. Interferon Res. 1980; 1(1)169
   Google Scholar
• Ingimarsson S., Cantell K., Carlstrom G., et al. Immune reactions and long-term therapy with human leukocyte interferon. Acta. Med. Scand. 1981; 209: 17
   Google Scholar
• Ingrimarsson S., Cantell K., Strander H. Side effects of long-term treatment with human leukocyte interferon. J. Infect. Dis. 1979; 140: 560
   Google Scholar
• Inoue M., Tan Y. H. Radioimmunoassay for human beta interferon. Infect. Immunity 1981; 33(3)763
   Google Scholar
• World Health Organization. Interferon and other antiviral agents, with special reference to influenza: A memorandum. Bull. WHO 1978; 56: 229
   Google Scholar
• Anon. Interferon nomenclature. Nature (London) 1980; 286: 110
   PubMedGoogle Scholar
• Anon. Interferon standards: A memorandum. J. Biol. Stand. 1979; 7: 383
   Google Scholar
• Report of WHO Scientific Group. Interferon therapy. Tech. Rep. Ser. 676, Worth Health Organization, Geneva 1982; 1
   Google Scholar
• Isaacs D., Clarke J. R., Tyrrell D. A. J., Webster A. D. B., Valman H. F. Deficient production of leucocyte interferon (interferon-) in vitro and in vivo in children with recurrent respiratory tract infections. Lancet 1981; 950
   Google Scholar
• Isaacs A., Burke D. C. Mode of action of interferon. Nature (London) 1958; 182: 1073
   Google Scholar
• Isaacs A., Lindemann J. D. Virus interference. I. Proc. Soc. Ser. B 1957; 147: 258
   PubMed Web of Science ®Google Scholar
• Isaacs A., Westwood M. A. Duration of protective action of interferon against infection with West Nile Virus. Nature (London) 1959; 184: 1232
   Google Scholar
• Izadkhah Z., Mandel A. D., Sonnenfeld G. Effect of treatment of mice with sera containing gamma interferon on the course of infection with Salmonella typhimurium Strain LT-2. J. Interferon Res. 1980; 1: 137
   Google Scholar
• Jameson P., Dixon M., Grossberg S. E. A sensitive interferon assay for many species of cells. Encephalomyocarditis virus hemagglutinin yield reduction. Proc. Soc. Biol. Med. 1977; 155: 173
   Google Scholar
• Jameson P., Schoenherr C. K., Grossberg S. E. Blue-tongue virus, an exceptionally potent interferon inducer in mice. Infect. Immunity 1978; 20: 321
   PubMed Web of Science ®Google Scholar
• Jesse R. H. Cancer of the Head and Neck, J. Y. Sven, E. N. Meyers. Churchill Livingstone, New York 1981; 10
   Google Scholar
• Joklik W. K. The molecular basis of the antiviral activity of interferons—introductory remarks. Ann. N.Y. Acad. Sci. 1980; 350: 432
   Google Scholar
• Joklik W. K., Merigan T. C. Concerning the mechanism of action of interferon. Proc. Natl. Acad. Sci. 1966; 56: 558
   PubMed Web of Science ®Google Scholar
• Jones B. R., Coster D. J., Falcon M. G., Cantell K. Clinical trials of topical interferon therapy of ulcerative viral keratitis. J. Infect. Dis. 1976; 113(A)169
   Google Scholar
• Jordan G. W., Fried R. P., Merigan T. C. Administration of human leukocyte interferon in Herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection. J. Infect. Dis. 1974; 130: 56
   PubMed Web of Science ®Google Scholar
• Kadish A. S., Doyle A. T., Steinhauer E. H., Ghossein N. A. Natural cytotoxicity and interferon production in human cancer: deficient natural killer activity and normal interferon production in patients with advanced disease. J. Immunol. 1981; 127(5)1817
   Google Scholar
• Kaempfer R., Israeli R., Roen H., Knoller S., Zilberstein A., Schmidt A., Revel M. Reversal of the interferon-induced block of protein synthesis by purified preparations of eukaryotic initiation factor 2. Virology 1979; 99: 179
   Google Scholar
• Keay S., Grossberg S. E. Interferon inhibits the conversion of 3T3 L1 mouse fibroblasts into adipocytes. Proc. Natl. Acad. Sci. 1980; 77: 4099
   PubMed Web of Science ®Google Scholar
• Kelsey D. K., Overall J. C., Jr., Glasgow L. A. Production of alpha and gamma interferons by spleen cells from cytomegalovirus-infected mice. Infect. Immunity 1982; 36(2)651
   Google Scholar
• Kerr I. M., Brown R. E., Ball L. A. Increased sensitivity to double-stranded RNA of protein synthesis in cell-free systems from interferon-treated cells. Nature (London) 1974; 250: 57
   Google Scholar
• Kerr I. M., Brown R. E., Hovanessian H. E. Nature of inhibitor of cell-free protein synthesis formed in response to interferon and double-stranded RNA. Nature (London) 1977; 268: 540
   PubMedGoogle Scholar
• Kerr I. M., Brown R. E. pppA2′p5′A2′p5′ A: An inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc. Natl. Acad. Sci. 1978; 15: 256
   Google Scholar
• Killender D., Lindahl P., Lundin L., Leary P., Cresser I. Relationship between the enhanced expression of histocompatibility antigens on interferon-treated L1210 cells and their position in the cell cycle. Eur. J. Immunol. 1976; 6: 56
   Google Scholar
• Klinkert W. E. F., LaBadie J. H., O'Brien J. P., Beyer C. F., Bowers W. E. Rat dendritic cells function as accessory cells and control the production of a soluble factor required for mitogenic responses of T lymphocytes. Proc. Natl. Acad. Sci. 1980; 77: 5414
   Google Scholar
• Koren H. S., Anderson S. J., Fischer D. G., Copeland C. S., Jensen P. J. Regulation of human natural killing. J. Immunol. 1981; 127(6)2207
   Google Scholar
• Korsaris A., Karemfillis T., Koliais S. I., Taylor-Papadimitriou J. Mitochondrial protein synthesis is inhibited by 2′–5′ linked oligoadenylic acid triphosphate. Biochem. Biophys. Res. Commun. 1980; 96: 1466
   Google Scholar
• Kortsaris A., Taylor-Papadimitriou J., Georgatsos J. G. Interferon inhibition of protein synthesis by isolated mitochondria. Biochem. Biophys. Res. Commun. 1976; 68(4)1317
   Google Scholar
• Koshland D. E., Jr., Nemethy G., Filmer D. Comparison of experimental binding data and theoretical models in proteins containing subunits. Biochemistry 1966; 5: 365
   PubMed Web of Science ®Google Scholar
• Krim M. Towards tumor therapy with interferons. I. Interferons: production and properties. Blood 1980; 55: 711
   PubMedGoogle Scholar
• Kushnaryov V. M., Sedmak J. J., Bendler J. W., III, Grossberg S. E. Ultrastructural localization of interferon receptors on the surfaces of cultured cells and erythrocytes. Infect. Immunity 1981; 36(2)811
   Google Scholar
• Kuwata T., Fuse A., Suzzuki N., Morinaga N. Comparison of the suppression of cell and virus growth in transformed human cells by leukocyte and fibroblast interferon. J. Gen. Virol. 1979; 43: 435
   Google Scholar
• Lebon P., Girard S., Thepot F., Chancy C. The presence of alpha-interferon in human amniotic fluid. J. Virol. 1982; 59: 393
   Google Scholar
• Lambert H. P., Stern H. Infective factors in exacerbations of bronchitis and asthma. Br. Med. J. 1972; 3: 323
   PubMedGoogle Scholar
• Lampson G., Tytell A., Field A., Nemesm Hilleman M. Inducers of interferon in host resistance. I. Double-stranded DNA from ext racts of penicillin fenculosom. Proc. Natl. Acad. Sci. 1967; 558: 782
   Google Scholar
• Langford M. P., Georgiardes J. A., Stanton G. J., Dianzani F., Johnson H. M. Large-scale production and physico-chemical characterization of human immune interferon. Infect. Immunity 1979; 26: 36
   PubMedGoogle Scholar
• Lawrence T. S., Beers W. H., Gilula N. B. Transmission of hormonal stimulation by cell-to-cell communication. Nature (London) 1978; 272: 501
   PubMed Web of Science ®Google Scholar
• Lawrence T. S., Beers W. H. Interferon-induced transfer of viral resistance between animal cells. Nature (London) 1977; 269: 422
   Google Scholar
• Leanderson T., Nordfelth R., Lundgren E. Antiproliferative effect of (2′–5′) oligoadenylate distinct from that of interferon in lymphoid cells. Biochem. Biophys. 1982; 107: 511
   PubMed Web of Science ®Google Scholar
• Lebleu B., Sen G. C., Shaila S., Cabrer B., Lengyel P. Interferon, double-stranded RNA, and protein phosphorylation. Proc. Natl. Acad. Sci. 1976; 73: 3107
   PubMed Web of Science ®Google Scholar
• Lee S. H. S., O'Shaughnessy M. V., Rozer K. R. Interferon induced growth depression in diploid and heterploid human cells. Proc. Soc. Exp. Biol. Med. 1972; 139: 1438
   Google Scholar
• Legaspi R. C., Catmaitan B., Bailey E. J., Lerner A. M. Interferon in biopsy and autopsy specimens of brain. Its presence in herpes simplex virus encephalitis. Arch. Neural. 1980; 37: 76
   PubMedGoogle Scholar
• Lengyel P. Biochemistry of interferons and their actions. Ann. Rev. Biochem. 1982; 51: 251
   PubMed Web of Science ®Google Scholar
• Lenz J. R., Baglioni C. Inhibition of protein synthesis by double-stranded RNA and phosphorylation of initiation factor eIF-2. J. Biol. Chem. 1978; 253: 4219
   PubMedGoogle Scholar
• Levine S. Effect of actinomycin D and puromycin dihydrochloride on action of interferon. Virology 1964; 24: 586
   PubMed Web of Science ®Google Scholar
• Levy H. B., Carter W. A. Molecular basis of the action of interferon. J. Mol. Biol. 1968; 31: 561
   Google Scholar
• Lewis J. A., Mengheri E., Esteban M. Induction of an antiviral response by interferon requires thymidine kinase. Proc. Natl. Acad. Sci. 1983; 80: 26
   PubMedGoogle Scholar
• Lindahl-Magnusson P., Leary P., Gresser I. Interferon inhibits DNA synthesis induced in mouse lympocyte suspensions by phytohaemagglutinin or by allogeneic cells. Nature New Biol. 1972; 237: 120
   PubMedGoogle Scholar
• Lundblad D., Lundgren E. Changes in DNA-polymerase and thymidine kinase activity during interferon treatment. Biochem. Biophys. 1982; 105: 1569
   Google Scholar
• Lundgren E., Larson I., Miorner H., Strannegard O. Effects of leukocyte and fibroblast interferon on events in the fibroblast cell cycle. J. Gen. Virol. 1979; 42: 589
   Google Scholar
• Maheshwari R. K., Streevalsan T., Silverman R. H., Hay J., Friedman R. M. Tunicamycin enhances the antiviral and anticellular activity of interferon. Science 1983; 219: 1339
   Google Scholar
• Malek-Mansour S. Immunotherapy of melanoma with 2–4 dinitrochlorobenzene (DNCB). Adjuvant Therapy of Cancer, S. E. Salmon, S. E. Jones. Elsevier/North Holland, Amsterdam 1977; 447
   Google Scholar
• Mannering G. S., Renton K. W., Azhary R., Deloria L. B. Effects of interferon inducing agents on hepatic cytochrome P. 450 drug metabolizing system. N.Y. Acad. Sci. 1980; 380: 314
   Google Scholar
• Marchinko V. I., Povalatski Y. L., Krivolchatskaya L. D. Interferon producing capacity of human tonsil cells and properties on interferon produced by these cells. Active Virol. 1976; 20: 114
   Google Scholar
• Marcus P. I., Terry T. M., Levine S. Interferon action. II. Membrane bound alkaline ribonuclease activity in chick embryo cells manifesting interferon-mediated interference. Proc. Natl. Acad. Sci. 1975; 72: 182
   Google Scholar
• McCabe B. F., Clark K. F. Interferon and laryngeal papillomatosis: the Iowa Experience. Ann. Otol. Rhinol. Laryngol. 1983; 92: 2
   PubMed Web of Science ®Google Scholar
• McIntosh K., Ellis E. F., Hoffman L. S., Lybass T. G., Eller J. J., Fulginita V. A. The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J. Pediat. 1973; 82: 578
   PubMed Web of Science ®Google Scholar
• Melder R. J., Ho M. Modulation of natural killer cell activity in mice after interferon induction: depression of activity and depression of in vitro enhancement by interferon. Infect. Immunity 1982; 36(3)990
   Google Scholar
• Meldolesi M. F., Friedman R. M., Kohn L. D. Interferon-induced increase in cyclic AMP levels proceeds the establishment of the antiviral state. Biochem. Biophys. Res. Commun. 1977; 79: 239
   Google Scholar
• Merigan T. C. Interferon—the first quarter century. JAMA 1982; 248: 2513
   Google Scholar
• Meyers J. D., McGuffin R. W., Byerson Y. J., Cantell K., Thomas E. D. Treatment of cytomegalovirus pneumonia after marrow transplant with combined vidarabine and hyman leukocyte interferon. J. Infect. Dis. 1982; 146(1)80
   Google Scholar
• Minor T. E., Dick E. C., Baker J. W., Ouellette J. J., Cohen M., Reed C. E. Rhinovirus and influenza type A infections as precipitants of asthma. Am. Rev. Respir. Dis. 1976; 113: 149
   PubMedGoogle Scholar
• Misset J. L., Mathe G., Gastiaburu J., Goutner A., Dorval T., Gouveia J., Hayat M., Jasmin C., Schwarzenberg L., Machover D., Ribaud P., De Vassal F., Horoszewicz J. S. Treatment of lymphoid neoplasias with interferon. I. Human fibroblastic β-interferon in malignant gammapathies. Phase II trial. Anticancer Res. 1982; 2: 63
   PubMed Web of Science ®Google Scholar
• Misste J. L., Mathe G., Gastiaburu J., Goutner A., Dorval T., Gouveia J., Hayat M., Jasmin C., Schwarzenberg L., Machover D., Ribaud P., De Vassal F. Treatment of lymphoid neoplasias with interferon. II. Human leucocyte α-interferon in chronic lymphatic leukemia (CLL). Phase I-II trial. Anticancer Res. 1982; 2: 67
   Google Scholar
• Miyoshi T., Ogawa S., Kanamori T., Nobuhara M., Namba M. Interferon potentiates cytotoxic effects of 5-fluorouracil on cell proliferation of established human cell lines originating from neoplastic tissues. Cancer Lett. 1983; 17: 239
   Google Scholar
• Morahan P. S., Grossberg S. E. Age-related cellular resistance of the chicken embryo to viral infections. I. Interferon and natural resistance to myxoviruses and vesicular stomatitis virus. J. Infect. Dis. 1970; 121: 615
   Google Scholar
• Morahan P. S., Grossberg S. E. Age-related cellular resistance of chicken embryo to viral infections. III. Escherichia coli resistant inducing protein. Proc. Exp. Biol. Med. 1970; 134: 342
   Google Scholar
• Nakane A., Minagawa T. Induction of alpha and beta interferons during the hyporeactive state of gamma interferon by mycobacterium bovis BCG cell wall fraction in mycobacterium bovis BCG sensitized mice. Infect. Immunol. 1982; 36: 966
   Google Scholar
• Neumann-Haefelin D., Sundmacher R., Skida R., Cantell K. Comparative evaluation of human leukocyte and fibroblast interferon in the prevention of herpes simplex virus keratitis in a monkey model. Infect. Immunol. 1977; 17(2)468
   Google Scholar
• Neurath A. R., Strick N., Raj N. B. K., Pitha P. M. Radioimmunoassay of human beta interferon. J. IFN Res. 1982; 2(1)51
   Google Scholar
• Ohno S., Kato F., Mutsuda H., Fujii N., Minagawa T. Detection of gamma interferon in the sera of patients with Behcet's disease. Infect. Immunity 1982; 36(1)202
   Google Scholar
• Ojo-Amaize E. A., Salimonu L. S., Williams A. I. O., Akinwolere O. A. O., Raad S., Gunnar V. A., Wigzell H. Positive correlation between degree of parasitemia, interferon titers, and natural killer cell activity in Plasmodium falciparum-infected children. J. Immunol. 1981; 127: 2296
   PubMed Web of Science ®Google Scholar
• Oldham R. R. Toxic effects on interferon. Science 1983; 219: 902
   Google Scholar
• Ortega J. A., Ma A., Shore N. A., Dukes P., Merigan T. C. Suppressive effect of interferon on erythroid cell proliferation. Exp. Hematol. 1979; 7: 145
   Google Scholar
• Panem S., personal communication.
   Google Scholar
• Panem S., Vilcek J. Interferon and the cure of cancer. The Atlantic Monthly December, 1982; 82
   Google Scholar
• Panje W. R. Regression of head and neck carcinoma with a prostaglandin synthesis inhibitor. Arch. Otolaryngol. 1981; 107: 658
   PubMedGoogle Scholar
• Paucker K., Dalton B. J., Ogburn C. A., Torma E. Multiple active sites on human interferon: (interferon antigens/heterospecific protection/rabbit cells/antibodies against interferon/affinity chromatograph). Proc. Natl. Acad. Sci. U.S.A. 1975; 72(11)4587
   Google Scholar
• Pazin G. J., Armstrong J. A., Lam M. T., Tarr G. C., Jannetta P. J., Ho M. Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root. N. Engl. J. Med. 1979; 301: 225
   PubMed Web of Science ®Google Scholar
• Pazin G. J., Ho M., Haverkos H. W., Armstrong J. A., Breinig M. C., Wechsler H. L., Arvin A., Merigan T. C., Cantell K. Effects of interferon-alpha on human warts. J. Interferon Res. 1982; 2(2)235
   Google Scholar
• Perussia B. Santoli, Daniela, and Trinchieri, Interferon modulation of natural killer cell activity. Ann. N.Y. Acad. Sci. 1980; 350: 55
   Google Scholar
• Pfeffer L. M., Wang E., Tamm I. Interferon effects on microfilament organization, cellular fibronectin distribution, and cell motility in human fibroblasts. J. Cell. Biol. 1980; 85: 9
   PubMed Web of Science ®Google Scholar
• Pfeffer L. M., Murphy J. S., Tamm I. Interferon effects on the growth and division of human fibroblasts. Exp. Cell. Res. 1979; 121: 111
   PubMed Web of Science ®Google Scholar
• Pickering L. A., Kronenberg L. H., Stewart W. E. II, Spontaneous production of human interferon. Proc. Natl. Acad. Sci. 1980; 77(10)5938
   Google Scholar
• Ponzio N. M., Fitzgerald K. L. Spontaneous production of T (Type II) interferon by a murine reticulum-cell sarcoma. N.Y. Acad. Sci. 1980; 350: 157
   Google Scholar
• Pouillart P., Palangie T., Jouve M., Garcia-Giralt E., Fridman W. H., Magdelenat H., Falcoff E., Billiaus A. Administration of fibroblast interferon to patients with advanced breast cancer: possible effects on skin metastasis and on hormone receptors. Eur. J. Cancer Clin. Oncol. 1982; 18: 929
   PubMedGoogle Scholar
• Preble O. T., Klippel J. H., Koffler D., Vilcek J., Friedman R. M. Interferon in systemic lupus erythematosus (Abstr. #0237). J. Cell Biochem. 1982; 6: 86
   Google Scholar
• Preble O. T., Black R. J., Friedman R. M. Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science 1982; 216: 429
   PubMed Web of Science ®Google Scholar
• Preble O. T., Costello L. E., Huang D. D., Barmada M. A. Neurovirulence mutant of vesicular stomatitis virus with an altered target cell tropism in vivo. Infect. Immunol. 1980; 29: 744
   Google Scholar
• Priestman T. J. Interferon: an anti-cancer agent?. Cancer Treat Rev. 1979; 6: 223
   PubMed Web of Science ®Google Scholar
• Quesada J. R., Swanson D. A., Trindade A., Gutterman J. U. Renal cell carcinoma: antitumor effects of leukocyte interferon. Cancer Res. 1983; 43: 940
   PubMed Web of Science ®Google Scholar
• Ratner L., Weigand R. C., Farrell P. J., Sen G. C., Cabrer B., Lengyel P. Interferon, double-stranded RNA and RNA degradation. Fractionation of the endo-nuclease system into two macromolecular components: role of a small molecule INT in nuclease activation. Biochem. Biophys. Res. Commun. 1978; 81: 947
   PubMedGoogle Scholar
• Revel M., Kimchi A., Shulman L., Fradin A., Shuster R., Yakobson E., Chernajovsky Y., Schmidt A., Shure A., Bendori R. Role of interferon-induced enzymes in the antiviral and antimitogenic effects of interferon. Conf. of regulatory functions of interferons. Ann. N.Y. Acad. Sci. 1980; 350: 459
   Google Scholar
• Riccardi C., Vose B. M., Herberman R. B. Modulation of IL 2-dependent growth of mouse NK cells by interferon and T lymphocytes. J. Immunol., 130: 228
   Google Scholar
• Rich S. A. Human lupus inclusions and interferon. Science 1981; 213: 772
   PubMed Web of Science ®Google Scholar
• Rich S. A., Owens T. B. Inducibility of human lupus inclusions of interferons (Abstr. 0279). J. Cell Biochem. 1982; 6(Suppl.)101
   Google Scholar
• Richtsmeier W. J., Grossberg S. E. The effects of mitochondrial metabolic inhibitors of interferon action (Abstr. 0257). J. Cell. Biochem. 1982; 6(Suppl.)94
   Google Scholar
• Richtsmeier W. J. Human interferon production in tonsil and adenoid tissue cultures. J. Am. Acad. Otolaryngol. Head Neck Surg. 1981; 89: 130, (Abstr); Am. J. Otolaryngol., 4, 325, 1983
   Google Scholar
• Richtsmeier W. J., Bowers W. E. Human tonsil and adenoid dendritic cells control IFN-γ production, unpublished results
   Google Scholar
• Ristow S. S., Starkey J. R., Hass G. M. Inhibition of natural killer cell activity in vitro by alcohols. Biochem. Biophys. Res. Commun. 1982; 105(4)1315
   Google Scholar
• Roberts W. K., Hovanessian A., Brown R. E., Clemens M. J., Kerr I. M. Interferon-mediated protein kinase and low-molecular-weight inhibitor of protein synthesis. Nature (London) 1976; 264: 477
   PubMed Web of Science ®Google Scholar
• Rossi G. B., Dolei A., Capobianchi M. R., Peschle C., Affabris E. Interactions of interferon with in vitro model systems involved in hematopoietic cell differentiation. Ann. N.Y. Acad. Sci. 1980; 350: 279
   PubMedGoogle Scholar
• Rubinstein S., Familletti C., Pestka S. Convenient assay for interferons. J. Virol. 1981; 37(2)755
   Google Scholar
• Saksela E., Timonen T. Cellular interactions in the augmentation of human NK activity by interferon. Ann. N.Y. Acad. Sci. 1980; 350: 102
   Google Scholar
• Samuel C. E., Farris D. A., Eppstein D. A. Mechanism of interferon action. Kinetics of interferon action in mouse L929 cells: translation inhibition, protein phosphorylation, and messenger RNA methylation and degradation. Virology 1977; 83: 56
   PubMedGoogle Scholar
• Samuel C. E., Joklik W. K. A protein synthesizing system from interferon-treated cells that discriminates between cellular and viral messenger RNAs. Virology 1974; 58: 476
   PubMed Web of Science ®Google Scholar
• Samuel C. E., Kingsman S. M., Melamed R. W., Farris D. A., Smith M. D., Miyamoto N. G., Lasky S. R., Knutson G. S. Mechanism of interferon-mediated inhibition of protein synthesis. Ann. N.Y. Acad. Sci. 1980; 350: 473
   Google Scholar
• Samuel C. E. Mechanism of interferon action. Kinetics of interferon action in mouse L929 cells: phosphorylation of protein synthesis initiation factor eIF-2 and ribosome-associated protein P1. Virology 1979; 93: 281
   Google Scholar
• Samuel C. E. Mechanism of interferon action. Phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase possessing site-specificity similar to the hemin-regulated rabbit reticulocyte kinase. Proc. Natl. Acad. Sci. 1979; 76: 600
   PubMed Web of Science ®Google Scholar
• Sanders C. V., Luby J. P., Sanford J. P., Hull A. R. Suppression of interferon response in lymphocytes from patients with uremia. J. Lab. Clin. Med. 1977; 77: 786
   Google Scholar
• Saneto R., Johnson H. M. Interferon inhibition of hexose monophosphate shunt activity as the mechanism of blocking differentiation of a preadipose cell line. Biochem. Biophys. Res. Commun. 1982; 106: 373
   Google Scholar
• Santoli D., Trinchieri G., Lief F. S. Cell-mediated cytoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocyte. J. Immunol. 1978; 121: 526
   PubMed Web of Science ®Google Scholar
• Santoli D., Trinchierei G., Koprowski H. Cell-mediated cytoxicity in humans against virus-infected target cells. II. Interferon induction and activation of natural killer cells. J. Immunol. 1978; 121: 532
   PubMed Web of Science ®Google Scholar
• Schattner A., Merlin G., Levin S., Wallach D., Hahn T., Revel M. Assay of an interferon-induced enzyme in white blood cells as a diganostic aid in viral diseases. Lancet 1981; 2: 497
   PubMedGoogle Scholar
• Schattner A., Merlin G., Wallach D., Rosenberg H., Bino T., Hahn T., Levin S., Revel M. Monitoring of interferon therapy by assay of (2′–5′) oligo-isoadenylate synthetase in human peripheral white blood cells. J. Interferon Res. 1981; 1(4)587
   Google Scholar
• Schouten T. J., Weimar W., Bos J. H., Box C. E., Cremers C. W., Schellekens H. Treatment of juvenile laryngeal papillomatosis with two types of interferon. Laryngoscope 1982; 92: 686
   PubMed Web of Science ®Google Scholar
• Schouten T. J., van den Broek P., Cremers, Cor W. R. J., Jongerius C. M., Meyer J. W. R., Vooys G. P. Interferons and bronchogenic charcinoma, in Juvenile Laryngeal Papillomatosis. Arch. Otolaryngol 1983; 109: 289
   PubMedGoogle Scholar
• Scorticatti C., DeLa Pena N. C., Bellora O. C., Mariotto R. A., Casabe A. R., Comilli R. Systemic IFN-alpha treatment of multiple bladder papilloma grade I or II patients: pilot study. J. Interferon Res. 1982; 2(3)339
   Google Scholar
• Scott G. M., Sceher D. S., Flowers D., et al. Clinical toxicity of interferon. Br. Med. J. 1981; 282: 1345
   PubMed Web of Science ®Google Scholar
• Scott G. M., Tyrrell D. A. J. Interferon: therapeutic fact or ′80s?. Br. Med. J. 1980; 280: 1558
   Google Scholar
• Scott G. M., Wallace J., Greiner J., Phillpotts R. J., Cauci C. L., Tyrrell D. A. J. Prevention of rhinohuman interferon alpha-s from Escherichia coli. Lancet 1982; 186
   Google Scholar
• Scott G. M., Secher D. S., Flowers D., et al. Clinical toxicity of interferon. Br. Med. J. 1981; 288: 1345
   Google Scholar
• Schullard G. H., Pollard R. B., Smith J. L., Sacks S. L., Gregory P. B., Robinson W. S., Merigan T. C. Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside. J. Infect. Dis. 1981; 143: 772
   Google Scholar
• Sedmak J. J., Grossberg S. E., Jameson P. The neuraminidase yield-reduction bioassay of human and other interferons (38822). Proc. Soc. Exp. Biol. Med. 1975; 149: 433
   Google Scholar
• Sehgal P. B., Sager A. D., Braude I. A. Further heterogencity of human interferon mRNA species. Science 1981; 214: 803
   PubMed Web of Science ®Google Scholar
• Sergiescu D., Cerutti I., Efthymiou E., Kahan A., Chany C. Adverse effects of interferon treatment on the life span of NZB mice. Biomedicine, 31: 48
   Google Scholar
• Sherwin S. A., Knost J. A., Fein S., Abrams P. G., Foon K. A., Ochs J. J., Schoenberger C., Maluish A. E., Oldham R. K. A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients. JAMA 1982; 248: 2461
   PubMed Web of Science ®Google Scholar
• Siegal G. P., Thorgeirsson U. P., Russo R. G., Wallace D. M., Liotta L. A., Berger S. L. Interferon enhancement of the invasive capacity of Ewing sarcoma cells in vitro. Proc. Natl. Acad. Sci. 1982; 79: 4064
   PubMed Web of Science ®Google Scholar
• Sikora K., Smedley H. Interferon and cancer. Br. Med. J. 1983; 286: 739
   Google Scholar
• Singh G., Renton K. W., Stebbing N. Homogeneous interferon from E. coli depresses hepatic cytochrome P-450 and drug biotransformation. Biochem. Biophys. Res. Commun. 1982; 106: 1256
   PubMed Web of Science ®Google Scholar
• Slimmer S., Masui H., Kaplan N. O. Antiproliferative assay for human interferons. Methods Enzymol. 1981; 79: 419
   Google Scholar
• Smedley H., Katrak M., Sikora K., Wheeler T. Neurological effects of recombinant human interferon. Br. Med. J. 1983; 286: 262
   PubMed Web of Science ®Google Scholar
• Smith E. M., Johnson H. M., Blalock J. E. Staphyloccus aureus protein A induces the production of interferon-α in human lymphocytes and interferon-α/β in mouse spleen cells. J. Immunol. 1983; 130: 773
   PubMed Web of Science ®Google Scholar
• Soloviev V. D. The results of controlled observations on the prophylaxis of influenza with interferon. Bull. WHO 1969; 41: 683
   Google Scholar
• Sonnenfeld G., Kierszenbaum F. Increased serum levels of an interferon-like activity during the acute period of experimental infection with different strains of Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 1981; 30: 1189
   Google Scholar
• Spruance S. L., Green J. A., Chiu G., Yeh T., Wenerstrom G., Overall J. C., Jr. Pathogenesis of herpes simplex labialis: correlation of vesicle fluid interferon with lesion age and virus titer. Infect. Immunity 1982; 36(3)907
   Google Scholar
• Stiehm E. R., Kronenberg L. H., Rosenblatt H. M., Bryson Y., Merigan T. C. Interferon: immunobiology and clinical significance, UCLA Conf. Ann. Int. Med. 1982; 96: 80
   PubMed Web of Science ®Google Scholar
• Stinebring W., Youngner J. Patterns of interferon appearance in mice injected with bacteria or bacterial endotoxin. Nature (London) 1964; 204: 1712
   Google Scholar
• Strander H., Cantell K. Production of interferon by human leukocytes in vitro. Ann. Med. Exp. Biol. Fenn. 1966; 44: 265
   Google Scholar
• Strander H., Einhorn S. Effect of human leukocyte interferon on the growth of human osteosarcoma cells in tissue culture. Int. J. Cancer 1977; 19: 468
   PubMed Web of Science ®Google Scholar
• Sundmacher R., Cantell K., Neumann-Haefelin D. Combination therapy of dendritic keratitis with trifluorothymidine and interferon. Lancet 1978; 2(8091)687
   Google Scholar
• Sundmacher A., Neumann-Haefelin D., Cantell K. Interferon treatment of dendritic keratitis. Lancet. 1976; 1186
   Google Scholar
• Sunkara P. S., Prakash N. J., Mayer G. D., Sjoerdsma A. Tumor suppression with a combination of α-difluoromethyl omithine and interferon. Science 1983; 219: 851
   PubMedGoogle Scholar
• Taylor J. Inhibition of interferon action by actinomycin. Biochem. Biophys. Res. Commun. 1964; 14: 447
   PubMed Web of Science ®Google Scholar
• Taylor-Papadimitriou J. The effects of interferon on cell growth and function. Interferon II, I. N. Gressor. Academic Press, New York 1980; 2
   Google Scholar
• Taylor-Papadimitriou J., Shearer M., Rozengurt E. Inhibitory effect of interferon on cellular DNA synthesis: modulation by pure mitogenic factors. J. Interferon Res. 1981; 1: 401
   PubMedGoogle Scholar
• Taylor J. L., Sabran J. L., Grossberg S. E. Cellular effects of interferon. Handbook of Experimental Pharmacology. Springer-Verlag, Basel 1982
   Google Scholar
• Taylor J. L., Schoenherr C. K., Grossberg S. E. High-yield interferon induction by 1-carboxymethyl-9-acridanone in mice and hamsters. Antimicrob. Agents Chemother. 1980; 18: 20
   PubMed Web of Science ®Google Scholar
• Tomida M., Yamamoto Y., Hozumi M. Stimulation by interferon of induction of differentiation of mouse myeloid leukemic cells. Cancer Res. 1980; 40: 2919
   PubMed Web of Science ®Google Scholar
• Treuner J., Niethammer D., Dannecker G., Hagmann R., Neef V., Hofschneider P. H. Successful treatment of nasopharyngeal carcinoma with interferon (letter to the Ed.). Lancet 1980; 817
   Google Scholar
• Trinchieri G., Santoli D. Antiviral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human NK cell activity by IFN and antagonistic inhibition of susceptibility of target cells to lysis. J. Exp. Med. 1978; 147: 1314
   PubMed Web of Science ®Google Scholar
• Trinchieri G., Santoli D., Knowles B. B. Tumor all lines induce interferon in human lymphocytes. Nature (London) 1977; 270: 611
   Google Scholar
• Trinchierei G., Santoli D., Koprowski H. Spontaneous cell-mediated cytoxicity in humans: role of IFN and immunoglobins. J. Immunol. 1978; 120: 1849
   Google Scholar
• Trinchierei G., Santoli D., Granato D., Perussia B. Antagonistic effects of interferon on the cytoxicity mediated by natural killer cells. Fed. Proc. 1981; 40: 2705
   Google Scholar
• Trying S., Klimpel G. R., Fleischmann W. R., Baron S. Direct cytolysis by partially purified preparations of immune interferon. Int. J. Cancer 1982; 30: 59
   Google Scholar
• Vallbracht A., Treuner J., Flehmig B., Joester K. E., Niethammer D. Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon. Nature (London) 1981; 289: 496
   Google Scholar
• Vallbracht A., Treuner J., Manncke K. H., Niethammer D. Autoantibodies against human beta interferon following treatment with interferon. J. IFN Res. 1982; 2: 107
   Google Scholar
• Vengris V. E., Stollar B. D., Pitha P. M. Interferon externalization by producing cell before induction of antiviral state. Virology 1975; 65: 410
   PubMed Web of Science ®Google Scholar
• Vianna N. J., Davies J. N., Harris S., Lawrence C. E., Arbuckle J., Marani W., Wilkinson J. Tonsillectomy and childhood Hodgkins disease. Lancet August 16, 1980
   Google Scholar
• Vilcek J. Interferon as a cell product. Adv. Exp. Med. Biol. 1979; 118: 117
   Google Scholar
• Vilcik J., Gresser I., Merigan T. C. Eds., Opening remarks—regulatory functions of interferons. Ann. N.Y. Acad. Sci. 1980; 350: 13
   Google Scholar
• Vose B. M., Riccardi C., Bonard G. D., Herberman R. R. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. J. Immunol. 1983; 130: 768
   PubMedGoogle Scholar
• Werenne J., Emonds-Alt X., Bartholeyns J. Interferon regulates cell motility. Ann. N.Y. Acad. Sci. 1980; 350: 623
   Google Scholar
• Wiebe M. E., Joklik W. K. The mechanism of inhibition of renovirus replication by interferon. Virology 1975; 66: 229
   Google Scholar
• Williams H., McNicol K. N. Prevalence, natural history, and relationship of wheezy bronchitis and asthma in children: An epidemiological study. Br. Med. J. 1969; 9: 321
   Google Scholar
• Wong T. W., Klinkert W. E. F., Bowers W. E. Immunological properties of thymus cell subpopulations: rat thymic dendritic cells are potent accessory cells and stimulators in a mixed leukocyte culture. Immunobiology 1982; 160: 413
   Google Scholar
• Wyler D. J., Liang L., Downey E., Krim M. Exogenous interferon administration in experimental Leishmaniasis: in vivo and in vitro studies. Am. J. Trop. Med Hyg. 1982; 3(4)740
   Google Scholar
• Yabrov A. A. Interferon and Non-specific Resistance. Human Sciences Press, New York 1980; 29
   Google Scholar
• Yaron M., Yaron I., Gurari-Rotman D., Revel M., Lindner H. R., Zor U. Stimulation of prostaglandin E production in cultured human fibroblasts by poly (I)-poly (C) and human interferon. Nature (London) 1977; 267: 4557
   Google Scholar
• Ytterberg S. R., Schnitzer T. J. Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum. Apr. 1982; 25: 401
   PubMed Web of Science ®Google Scholar
• Zawatzky R., Gresser I., DcMaeyer E., Kirchner H. The role of interferon in the resistance of C57BL/6 mice to various doses of herpes simplex virus type I. J. Infect. Dis. 1982; 146: 405
   PubMedGoogle Scholar
• Zilberstein A., Federman J. P., Shulman L., Revel M. Specific phosphorylation in vitro of a protein associated with ribosomes of interferon-treated mouse cells. FEBS Lett. 1976; 68: 119
   PubMedGoogle Scholar